K. M. Petersen

Monitoring the effect of belinostat in solid tumors by H4 acetylation

M. Sehested, M. Persson, P. B. Jensen, 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Activity of PXD101, a histone deacetylase inhibitor, in preclinical ovarian cancer studies

M. Sehested, M. Jeffers, Xiaozhong Qian, 2006, Molecular Cancer Therapeutics.

Gene expression-signature of belinostat in cell lines is specific for histone deacetylase inhibitor treatment, with a corresponding signature in xenografts

A. Monks, R. Shoemaker, C. Hose, 2009, Anti-cancer drugs.

The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo

M. Sehested, A. Tumber, L. Collins, 2007, Cancer Chemotherapy and Pharmacology.

Novel amide derivatives as inhibitors of histone deacetylase: design, synthesis and SAR.

Ivars Kalvinsh, Anthony Tumber, Nagma Khan, 2009, European journal of medicinal chemistry.